Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Study to Explore the Association of the Renin-Angiotensin System and Right Ventricular Function in Mechanically Ventilated Patients.
Journal: Journal of clinical medicine
Published: May 11, 2022
An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension.
Journal: Pulmonary circulation
Published: May 05, 2021
Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study.
Journal: Pulmonary therapy
Published: April 15, 2021
CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin.
Journal: ERJ open research
Published: August 17, 2020
Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge.
Journal: Pulmonary pharmacology & therapeutics
Published: August 07, 2020
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.
Journal: International journal of chronic obstructive pulmonary disease
Published: June 11, 2020
A nebulised antitumour necrosis factor receptor-1 domain antibody in patients at risk of postoperative lung injury: A randomised, placebo-controlled pilot study.
Journal: European journal of anaesthesiology
Published: May 30, 2020
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
Journal: Respiratory research
Published: January 15, 2020
Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study.
Journal: Critical care (London, England)
Published: August 30, 2019
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Food Effect of Danirixin Hydrobromide Tablets in Japanese Healthy Elderly Participants.
Journal: Clinical pharmacology in drug development
Published: November 01, 2018
Effect of the CXCR2 antagonist danirixin on symptoms and health status in COPD.
Journal: The European respiratory journal
Published: January 26, 2018
Pharmacokinetics, Excretion, and Mass Balance of [14 C]-Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy Men.
Journal: Clinical pharmacology in drug development
Published: September 11, 2017
Last Updated: 09/26/2026